CARRIE SMITH COX Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARRIE SMITH COX.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARRIE SMITH COX. CARRIE SMITH COX is Director in CARDINAL HEALTH INC ($CAH) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Executive Vice President in Merck & Co., Inc. ($MRK) and Director in TEXAS INSTRUMENTS INC ($TXN) and in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in electroCore, Inc. ($ECOR) and Director in Organon & Co. ($OGN).
Latest Insider Trading Transactions of CARRIE SMITH COX
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARRY, CAH, CELG, ECOR, MRK, OGN, SELB, TXN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | OGN | Organon & Co. | COX CARRIE SMITH | Director | Option Exercise | A | 0.00 | 18,079 | 0 | 18,079 | |
Apr 01 2021 | SELB | SELECTA BIOSCIENCE ... | COX CARRIE SMITH | Director | Option Exercise | A | 4.01 | 60,000 | 240,600 | 60,000 | |
Feb 01 2021 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | A | 169.23 | 2,457 | 415,798 | 2,457 | |
Feb 01 2021 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 590 | 0 | 34,655 | 34.1 K to 34.7 K (+1.73 %) |
Nov 10 2020 | CAH | CARDINAL HEALTH IN ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 3,339 | 0 | 35,614 | 32.3 K to 35.6 K (+10.35 %) |
Oct 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 53.94 | 10,539 | 568,474 | 0 | |
Oct 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 44.09 | 12,299 | 542,263 | 0 | |
Oct 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Sell | S | 149.31 | 22,838 | 3,409,978 | 34,065 | 56.9 K to 34.1 K (-40.13 %) |
Oct 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 53.94 | 10,539 | 568,474 | 56,903 | 46.4 K to 56.9 K (+22.73 %) |
Oct 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 44.09 | 12,299 | 542,263 | 46,364 | 34.1 K to 46.4 K (+36.10 %) |
Jul 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 32.80 | 14,749 | 483,767 | 0 | |
Jul 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 32.36 | 12,156 | 393,368 | 0 | |
Jul 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Sell | S | 130.00 | 26,905 | 3,497,650 | 34,065 | 61 K to 34.1 K (-44.13 %) |
Jul 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 32.80 | 14,749 | 483,767 | 60,970 | 46.2 K to 61 K (+31.91 %) |
Jul 27 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 32.36 | 12,156 | 393,368 | 46,221 | 34.1 K to 46.2 K (+35.68 %) |
Jun 23 2020 | SELB | SELECTA BIOSCIENCE ... | COX CARRIE SMITH | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
Jan 28 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | A | 130.52 | 3,911 | 510,464 | 3,911 | |
Jan 28 2020 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 766 | 0 | 34,065 | 33.3 K to 34.1 K (+2.30 %) |
Dec 26 2019 | SELB | SELECTA BIOSCIENCE ... | COX CARRIE SMITH | Director | Option Exercise | A | 1.46 | 32,840 | 47,946 | 32,840 | |
Dec 26 2019 | SELB | SELECTA BIOSCIENCE ... | COX CARRIE SMITH | Director | Grant | A | 1.46 | 65,681 | 95,894 | 65,681 | 0 to 65.7 K |
Nov 22 2019 | SELB | SELECTA BIOSCIENCE ... | COX CARRIE SMITH | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 0.00 | 1,125 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 0.00 | 1,000 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 0.00 | 6,200 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 0.00 | 4,756 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 0.00 | 1,454 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 0.00 | 900 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 77.38 | 13,266 | 1,026,523 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 121.04 | 10,500 | 1,270,920 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 99.98 | 11,000 | 1,099,780 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 112.16 | 10,000 | 1,121,600 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 88.50 | 20,700 | 1,831,950 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 59.06 | 18,600 | 1,098,516 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 31.80 | 18,600 | 591,480 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | D | 29.00 | 18,600 | 539,400 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Sell | D | 0.00 | 39,535 | 0 | 0 | 39.5 K to 0 (-100.00 %) | |
Nov 13 2019 | CAH | CARDINAL HEALTH IN ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 3,424 | 0 | 32,275 | 28.9 K to 32.3 K (+11.87 %) |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | D | 14.93 | 25,000 | 373,250 | 0 | |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Sell | D | 48.00 | 8,000 | 384,000 | 10,000 | 18 K to 10 K (-44.44 %) |
Jun 11 2019 | ECOR | electroCore, Inc. | COX CARRIE SMITH | Director | Option Exercise | A | 0.00 | 66,964 | 0 | 66,964 | |
Jun 06 2019 | ECOR | electroCore, Inc. | COX CARRIE SMITH | Director | Buy | P | 1.82 | 10,000 | 18,200 | 21,000 | 11 K to 21 K (+90.91 %) |
Jun 05 2019 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | A | 0.00 | 4,756 | 0 | 4,756 | ||
May 01 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 34.63 | 10,002 | 346,369 | 0 | |
May 01 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 23.05 | 7,000 | 161,350 | 0 | |
May 01 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Sell | S | 116.08 | 17,002 | 1,973,572 | 33,299 | 50.3 K to 33.3 K (-33.80 %) |
May 01 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 34.63 | 10,002 | 346,369 | 50,301 | 40.3 K to 50.3 K (+24.82 %) |
May 01 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 23.05 | 7,000 | 161,350 | 40,299 | 33.3 K to 40.3 K (+21.02 %) |
Feb 21 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Buy | P | 23.20 | 5,000 | 115,998 | 8,000 | 3 K to 8 K (+166.67 %) | |
Jan 29 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | A | 104.41 | 4,532 | 473,186 | 4,532 | |
Jan 29 2019 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 957 | 0 | 33,299 | 32.3 K to 33.3 K (+2.96 %) |
Dec 04 2018 | ECOR | electroCore, Inc. | COX CARRIE SMITH | Director | Buy | P | 6.78 | 900 | 6,106 | 11,000 | 10.1 K to 11 K (+8.91 %) |
Dec 04 2018 | ECOR | electroCore, Inc. | COX CARRIE SMITH | Director | Buy | P | 6.79 | 6,400 | 43,480 | 10,100 | 3.7 K to 10.1 K (+172.97 %) |
Nov 13 2018 | CAH | CARDINAL HEALTH IN ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 3,164 | 0 | 28,851 | 25.7 K to 28.9 K (+12.32 %) |
Nov 05 2018 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Buy | P | 16.87 | 3,000 | 50,595 | 3,000 | 0 to 3 K | |
Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Option Exercise | A | 14.55 | 25,000 | 363,750 | 25,000 | ||
Aug 20 2018 | ECOR | electroCore, Inc. | COX CARRIE SMITH | Director | Buy | P | 13.76 | 3,700 | 50,919 | 17,033 | 13.3 K to 17 K (+27.75 %) |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | A | 14.93 | 25,000 | 373,250 | 25,000 | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jun 14 2018 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | A | 0.00 | 1,454 | 0 | 1,454 | ||
Jun 14 2018 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | A | 77.38 | 13,266 | 1,026,523 | 13,266 | ||
Jun 14 2018 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Option Exercise | M | 0.00 | 6,200 | 0 | 0 | ||
Jun 14 2018 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Buy | M | 0.00 | 6,200 | 0 | 30,080 | 23.9 K to 30.1 K (+25.96 %) | |
Jan 29 2018 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | A | 110.15 | 4,306 | 474,306 | 4,306 | |
Jan 29 2018 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 907 | 0 | 32,342 | 31.4 K to 32.3 K (+2.89 %) |
Nov 09 2017 | CAH | CARDINAL HEALTH IN ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 2,623 | 0 | 25,687 | 23.1 K to 25.7 K (+11.37 %) |
Jul 31 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 14.95 | 7,000 | 104,650 | 0 | |
Jul 31 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 29.79 | 7,000 | 208,530 | 0 | |
Jul 31 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Sell | S | 82.25 | 14,000 | 1,151,500 | 31,435 | 45.4 K to 31.4 K (-30.81 %) |
Jul 31 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 14.95 | 7,000 | 104,650 | 45,435 | 38.4 K to 45.4 K (+18.21 %) |
Jul 31 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 29.79 | 7,000 | 208,530 | 38,435 | 31.4 K to 38.4 K (+22.27 %) |
Jul 05 2017 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 734 | 0 | 0 | |
Jul 05 2017 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 734 | 0 | 23,880 | 23.1 K to 23.9 K (+3.17 %) |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | A | 0.00 | 900 | 0 | 900 | |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | A | 121.04 | 10,500 | 1,270,920 | 10,500 | |
Jan 30 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | A | 79.26 | 6,065 | 480,712 | 6,065 | |
Jan 30 2017 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 1,261 | 0 | 31,435 | 30.2 K to 31.4 K (+4.18 %) |
Nov 07 2016 | CAH | CARDINAL HEALTH IN ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 2,447 | 0 | 23,064 | 20.6 K to 23.1 K (+11.87 %) |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 733 | 0 | 23,146 | 22.4 K to 23.1 K (+3.27 %) |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 733 | 0 | 23,146 | 22.4 K to 23.1 K (+3.27 %) |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 733 | 0 | 23,146 | 22.4 K to 23.1 K (+3.27 %) |
Jun 17 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 6,200 | 0 | 0 | |
Jun 17 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | A | 0.00 | 1,125 | 0 | 1,125 | |
Jun 17 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | A | 99.98 | 11,000 | 1,099,780 | 11,000 | |
Jun 17 2016 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 6,200 | 0 | 22,413 | 16.2 K to 22.4 K (+38.24 %) |
Feb 01 2016 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | A | 52.93 | 9,990 | 528,771 | 9,990 | |
Feb 01 2016 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 1,889 | 0 | 30,174 | 28.3 K to 30.2 K (+6.68 %) |
Nov 05 2015 | CAH | CARDINAL HEALTH IN ... | COX CARRIE SMITH | Director | Grant | A | 0.00 | 1,848 | 0 | 20,617 | 18.8 K to 20.6 K (+9.85 %) |
Jul 28 2015 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 28.32 | 7,000 | 198,240 | 0 | |
Jul 28 2015 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Option Exercise | M | 32.55 | 15,000 | 488,250 | 0 | |
Jul 28 2015 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Sell | S | 50.00 | 7,000 | 350,000 | 28,285 | 35.3 K to 28.3 K (-19.84 %) |
Jul 28 2015 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Sell | S | 50.00 | 15,000 | 750,000 | 28,285 | 43.3 K to 28.3 K (-34.65 %) |
Jul 28 2015 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 28.32 | 7,000 | 198,240 | 35,285 | 28.3 K to 35.3 K (+24.75 %) |
Jul 28 2015 | TXN | TEXAS INSTRUMENTS ... | COX CARRIE SMITH | Director | Buy | M | 32.55 | 15,000 | 488,250 | 43,285 | 28.3 K to 43.3 K (+53.03 %) |
Jul 06 2015 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 733 | 0 | 1,467 | |
Jul 06 2015 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 733 | 0 | 16,213 | 15.5 K to 16.2 K (+4.74 %) |
Jun 19 2015 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Jun 19 2015 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | A | 112.16 | 10,000 | 1,121,600 | 10,000 | |
Jun 16 2015 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Option Exercise | M | 0.00 | 2,050 | 0 | 0 | |
Jun 16 2015 | CELG | CELGENE CORP /DE/ | COX CARRIE SMITH | Director | Buy | M | 0.00 | 2,050 | 0 | 15,480 | 13.4 K to 15.5 K (+15.26 %) |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | D | 0.00 | 66,552 | 0 | 0 | |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | D | 22.91 | 264,600 | 6,061,986 | 0 | |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | D | 18.85 | 270,000 | 5,089,500 | 0 | |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | D | 20.70 | 400,000 | 8,280,000 | 0 | |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | D | 31.57 | 400,000 | 12,628,000 | 0 | |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | D | 19.23 | 375,000 | 7,211,250 | 0 | |
Nov 04 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | D | 0.00 | 169,534 | 0 | 0 | 169.5 K to 0 (-100.00 %) |
May 05 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | A | 22.91 | 264,600 | 6,061,986 | 264,600 | |
Apr 03 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | M | 0.00 | 70,000 | 0 | 0 | |
Apr 03 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Payment of Exercise | F | 23.70 | 32,445 | 768,947 | 169,534 | 202 K to 169.5 K (-16.06 %) |
Apr 03 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Buy | M | 0.00 | 70,000 | 0 | 201,979 | 132 K to 202 K (+53.04 %) |
Mar 03 2009 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | A | 0.00 | 66,163 | 0 | 66,163 | |
May 05 2008 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | A | 18.85 | 270,000 | 5,089,500 | 270,000 | |
Apr 29 2008 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | M | 0.00 | 76,000 | 0 | 70,000 | |
Apr 29 2008 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Payment of Exercise | F | 18.64 | 35,226 | 656,613 | 131,979 | 167.2 K to 132 K (-21.07 %) |
Apr 29 2008 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Buy | M | 0.00 | 76,000 | 0 | 167,205 | 91.2 K to 167.2 K (+83.33 %) |
May 03 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | A | 31.57 | 400,000 | 12,628,000 | 400,000 | |
May 03 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | M | 18.50 | 450,000 | 8,325,000 | 0 | |
May 03 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 31.50 | 443,700 | 13,976,550 | 91,205 | 534.9 K to 91.2 K (-82.95 %) |
May 03 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 31.51 | 6,300 | 198,513 | 534,905 | 541.2 K to 534.9 K (-1.16 %) |
May 03 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Buy | M | 18.50 | 450,000 | 8,325,000 | 541,205 | 91.2 K to 541.2 K (+493.39 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Option Exercise | M | 18.20 | 450,000 | 8,190,000 | 0 | |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.59 | 10,700 | 327,313 | 91,205 | 101.9 K to 91.2 K (-10.50 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.60 | 19,800 | 605,880 | 101,905 | 121.7 K to 101.9 K (-16.27 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.61 | 8,500 | 260,185 | 121,705 | 130.2 K to 121.7 K (-6.53 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.66 | 16,900 | 518,154 | 130,205 | 147.1 K to 130.2 K (-11.49 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.67 | 14,400 | 441,648 | 147,105 | 161.5 K to 147.1 K (-8.92 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.68 | 5,800 | 177,944 | 161,505 | 167.3 K to 161.5 K (-3.47 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.69 | 2,500 | 76,725 | 167,305 | 169.8 K to 167.3 K (-1.47 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.70 | 800 | 24,560 | 169,805 | 170.6 K to 169.8 K (-0.47 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.71 | 7,400 | 227,254 | 170,605 | 178 K to 170.6 K (-4.16 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.80 | 4,000 | 123,200 | 178,005 | 182 K to 178 K (-2.20 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.81 | 500 | 15,405 | 182,005 | 182.5 K to 182 K (-0.27 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.82 | 16,700 | 514,694 | 182,505 | 199.2 K to 182.5 K (-8.38 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.86 | 13,200 | 407,352 | 199,205 | 212.4 K to 199.2 K (-6.21 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.87 | 22,800 | 703,836 | 212,405 | 235.2 K to 212.4 K (-9.69 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.88 | 14,600 | 450,848 | 235,205 | 249.8 K to 235.2 K (-5.84 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.89 | 42,800 | 1,322,092 | 249,805 | 292.6 K to 249.8 K (-14.63 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.90 | 39,300 | 1,214,370 | 292,605 | 331.9 K to 292.6 K (-11.84 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.91 | 31,400 | 970,574 | 331,905 | 363.3 K to 331.9 K (-8.64 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.92 | 155,300 | 4,801,876 | 363,305 | 518.6 K to 363.3 K (-29.95 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.93 | 11,700 | 361,881 | 518,605 | 530.3 K to 518.6 K (-2.21 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.94 | 3,700 | 114,478 | 530,305 | 534 K to 530.3 K (-0.69 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 30.95 | 2,300 | 71,185 | 534,005 | 536.3 K to 534 K (-0.43 %) |
Apr 24 2007 | MRK | Merck & Co., I ... | COX CARRIE SMITH | Executive Vice Pres ... | Sell | S | 31.01 | 3,000 | 93,030 | 536,305 | 539.3 K to 536.3 K (-0.56 %) |